NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

Código QR

NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study

Background. The prognostic significance of the amino-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has not been fully elucidated. Major adverse cardiova...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zuoan Qin, Yaoyao Du, Quan Zhou, Xuelin Lu, Li Luo, Zhixiang Zhang, Ning Guo, Liangqing Ge
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/341f4e1098874b9782fcaa01026b81b7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Relationship between fragmented QRS and NT proBNP in patients with ST elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Sunil Subhash Bobade
Publicado: (2021)

NT-ProBNP levels in saliva and its clinical relevance to heart failure.
por: Jared Yong Yang Foo, et al.
Publicado: (2012)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
por: Bader Alsuwailem, et al.
Publicado: (2021)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
por: Lidia Staszewsky, et al.
Publicado: (2021)

Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
por: Volker H. Schmitt, et al.
Publicado: (2021)

The Ratio of NT-proBNP to CysC1.53 Predicts Heart Failure in Patients With Chronic Kidney Disease
por: Sheng Wang, et al.
Publicado: (2021)

Association of NT-proBNP and multiple biomarkers with severity of angiographic coronary artery disease in diabetic and pre-diabetic Chinese patients.
por: Zhou Fang, et al.
Publicado: (2011)

Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
por: Marina Rudman, et al.
Publicado: (2021)

NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the SAfrEIC study.
por: Ruan Kruger, et al.
Publicado: (2013)

Effect of various weight loss interventions on serum NT-proBNP concentration in severe obese subjects without clinical manifest heart failure
por: Tim Hollstein, et al.
Publicado: (2021)

Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.
por: Esther Roselló-Lletí, et al.
Publicado: (2012)

Role of NT-pro BNP in predicting mortality in heart failure
por: Kamal Kant Jena, et al.
Publicado: (2021)

Extracellular matrix biomarker, fibulin-1, is closely related to NT-proBNP and soluble urokinase plasminogen activator receptor in patients with aortic valve stenosis (the SEAS study).
por: Ruan Kruger, et al.
Publicado: (2014)

The ability of NT-proBNP to detect chronic heart failure and predict all-cause mortality is higher in elderly Chinese coronary artery disease patients with chronic kidney disease
por: Fu S, et al.
Publicado: (2013)

Correlation between plasma proBNP, echocardiographic and clinical parameters in patientswith type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention
por: Yujing Diao, et al.
Publicado: (2021)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao L, et al.
Publicado: (2014)

MRI discriminates thrombus composition and ST resolution after percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
por: Ignasi Barba, et al.
Publicado: (2011)

Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction
por: Marta Kurdziel, et al.
Publicado: (2021)

Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST‐Segment–Elevation Myocardial Infarction
por: Samian Sulaiman, et al.
Publicado: (2021)

OUTCOMES OF TRANSRADIAL APPROACH IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
por: Amna Rashdi, et al.
Publicado: (2020)

Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction with ST Segment-Elevation: Effect on the Severity of Ischemic Mitral Regurgitation
por: Mohammad Aly Hammad, et al.
Publicado: (2021)

The Association of Atrial Fibrillation Before Percutaneous Coronary Intervention With 1-Year Outcome in ST-Elevation Myocardial Infarction Patients
por: Eero Anttonen, MD, et al.
Publicado: (2021)

MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction
por: Shengjue Xiao, et al.
Publicado: (2021)

Comparison of infarction size, complete ST-segment resolution incidence, mortality and re-infarction and target vessel revascularization between remote ischemic conditioning and ischemic postconditioning in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
por: Haozhou Zhang, et al.
Publicado: (2020)

Fabrication and microfluidic analysis of graphene-based molecular communication receiver for Internet of Nano Things (IoNT)
por: Murat Kuscu, et al.
Publicado: (2021)

Patient Radiation Exposure During Primary Percutaneous Coronary Intervention in Acute ST-elevation Myocardial Infarction at the Philippine Heart Center
por: Emily Mae L Yap, et al.
Publicado: (2021)

Randomized comparative study of left versus right radial approach in the setting of primary percutaneous coronary intervention for ST-elevation myocardial infarction
por: Fu Q, et al.
Publicado: (2015)

OUTCOME OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION ARRIVING IN ARMY CARDIAC CENTER LAHORE
por: Khurram Shahzad, et al.
Publicado: (2020)

Prognostic nutritional index predicts clinical outcome in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Qing-Jie Chen, et al.
Publicado: (2017)

Dynamics of biochemical markers of systemic inflammatory response and renal functional condition in patients with myocardial infarction without ST elevation in the dependence of percutaneous angioplasty
por: V.P. Ivanov, et al.
Publicado: (2018)

BNP signaling is crucial for embryonic stem cell proliferation.
por: Essam Mohamed Abdelalim, et al.
Publicado: (2009)

COMPARISON OF EFFECT OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION WITH STREPTOKINASE IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION (STEMI) ON LEFT VENTRICULAR FUNCTION AFTER 3 MONTHS
por: Saleha Abbas, et al.
Publicado: (2020)

Effect of prasugrel versus ticagrelor on coronary microperfusion in ST elevation myocardial infarction patients undergoing percutaneous coronary angioplasty - Acute and short term results
por: Rupesh Santosh Agrawal, et al.
Publicado: (2021)

Sex-specific mortality prediction by pro-C-type natriuretic peptide measurement in a prospective cohort of patients with ST-elevation myocardial infarction
por: Jacob Eifer Moller, et al.
Publicado: (2021)

The CADILLAC risk score accurately identifies patients at low risk for in-hospital mortality and adverse cardiovascular events following ST elevation myocardial infarction
por: Ryan S. Wilson, et al.
Publicado: (2021)

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
por: Mohammad Zubaid, et al.
Publicado: (2020)

Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Jianwei Zhang, et al.
Publicado: (2021)

Incidence of atrial fibrillation and its effects on long-term follow-up outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
por: Şükrü Arslan, et al.
Publicado: (2021)